This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A growing consumer demand for sustainable and health-focused travel options is pushing the hospitality industry to innovate and prioritize wellness to meet these evolving expectations. LEMI’s versatile tables, for example, exemplify this innovation, offering multifunctionality that adapts to small spa environments.
“The approval of JUVÉDERM VOLUMA XC to treat temple hollows further demonstrates Allergan Aesthetics commitment to innovation and addressing patient needs,” says Carrie Strom, President, Allergan Aesthetics and Senior Vice President, AbbVie, in a news release. “This is the first U.S.
“These formulations enhance overall skin texture, underscoring our commitment to integrating cutting-edge scientific research and ingredients into practical, effective skincare solutions,” says Eman Kadhim, Head of Scientific Communications & Upstream Innovation at Waldencast, in a news release.
The Phase 1 trial is a first-in-human, randomized, double-blind, placebo-controlled study designed to evaluate the safety and PK of APG777 in healthy volunteers. At Apogee, we refuse to stop at good enough and are dedicated to advancing innovative solutions for patients.
The pharmacology, toxicity, and safety data for NO use in humans has been well-established for decades. For a full list of Marinomed’s portfolio of Carragelose® containing nasal sprays and oral products, please visit [link] , for a list of scientific publications on Carragelose®, [link].
There, he led the Product Safety group for 25 years. His product safetyportfolio included: Jergens and Curel lotions, Biore face care, Ban antiperspirant, and John Frieda hair care. As a result, the products being developed met the expected safety standards and regulatory requirements upon launch.
Next up, we’ll be tackling the topic of safety, coming your way in late September. IBA supports creative, innovative companies from startups to established multinational businesses of all sizes succeed in the rapidly changing, highly competitive global cosmetics and personal care industry. in both Skin Care and Hair Care.
This milestone represents an exciting new chapter in our long-term strategy to expand our portfolio and transition from a single-product company to a multi-product innovator, strengthening our leadership in performance beauty, says David Moatazedi, President and Chief Executive Officer of Evolus, in a news release.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content